Multimodal Imaging and Detection Strategy With 124 I-Labeled Chimeric Monoclonal Antibody cG250 for Accurate Localization and Confirmation of Extent of Disease During Laparoscopic and Open Surgical Resection of Clear Cell Renal Cell Carcinoma

Renal cell carcinoma (RCC) accounts for approximately 85% to 90% of all primary kidney malignancies, with clear cell RCC (ccRCC) constituting approximately 70% to 85% of all RCCs. This study describes an innovative multimodal imaging and detection strategy that uses (124)I-labeled chimeric monoclona...

Descripción completa

Detalles Bibliográficos
Autores principales: Povoski, Stephen P., Hall, Nathan C., Murrey, Douglas A., Sharp, David S., Hitchcock, Charles L., Mojzisik, Cathy M., Bahnson, Eamonn E., Knopp, Michael V., Martin, Edward W., Bahnson, Robert R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758170/
https://www.ncbi.nlm.nih.gov/pubmed/22455975
http://dx.doi.org/10.1177/1553350612438416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758170/
https://www.ncbi.nlm.nih.gov/pubmed/22455975
http://dx.doi.org/10.1177/1553350612438416

Ejemplares similares